Chamberlain, M.C.

patient trial glioma imaging study assessment response treatment tumor point brain survival symptom seizure cancer progression therapy bene fit diagnosis outcome function nerve criteria oncol disease j clin oncol group phase tumour change end point measure review center neuro-oncology end points neurolymphomatosi lymphoma neurologic hrqol increase erasmus universiteit rotterdam activity university factor radiotherapy neurology report department involvement volume patient function response assessment contrast enhancement series measurement table flair trial end points status baseline neuropathy j neurooncol nding literature plexu temozolomide leukemia phase ii studies neurocognitive e ffect growth chemotherapy biopsy objective radiation information endpoint cranial